Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer
- 123 Downloads
Cyclooxygenase (COX) is the rate-limiting enzyme in the synthesis of prostaglandins. It exists in two isoforms: COX-1 which is constitutively expressed and COX-2 which is an inducible form activated by a variety of cytokines during inflammation.
Interest in this enzyme arose in the early 1990s when, following epidemiological studies, aspirin (which is a COX inhibitor) was found to reduce the risk of colorectal cancer. Since then various studies to decipher the mechanisms by which COX reduces the development of colorectal cancer have been undertaken. One of the mechanisms being studied is its role in the angiogenesis of colorectal cancer. Angiogenesis of its own has been well established as a key factor in the development of tumours. Agents that specifically inhibit COX-2 are now in clinical development and have been licensed to be used in patients with familial adenomatosis polyposis.
What needs to be determined is whether the antiangiogenic effects of COX-2 inhibitors can be used in the prevention and/or treatment of colorectal cancer and its metastases.
KeywordsColorectal cancer Angiogenesis Cyclooxygenase Cyclooxygenase inhibitor
- 10.Thun MJ, Namboodiri MM, Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593–1596Google Scholar
- 12.DuBois RN (2000) Review article: cyclooxygenase-a target for colon cancer prevention. Aliment Pharmacol Ther 14 [Suppl 1]:64–67Google Scholar
- 13.Chen WS, Wei SJ, Liu JM, Hsiao M, Kou-Lin J, Yang WK (2001) Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int J Cancer 91:894–899Google Scholar
- 22.Vane JR, Botting RMr (2001) Therapeutic roles of selective COX-2 inhibitors. Harvey, LondonGoogle Scholar
- 31.Crew TE, Elder DJ, Paraskeva C (2000) A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate. Carcinogenesis 21:69–77CrossRefPubMedGoogle Scholar
- 34.Elder DJ, Halton DE, Crew TE, Paraskeva C (2000) Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int J Cancer 86:553–560Google Scholar
- 47.Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T, et al (2000) Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer 83:324–328Google Scholar
- 62.Dicker AP, Williams TL, Grant DS (2001) Targeting angiogenic processes by combination rofecoxib and ionizing radiation. Am J Clin Oncol 24:438–442Google Scholar
- 72.Tomozawa S, Nagawa H, Tsuno N, Hatano K, Osada T, Kitayama J, et al (1999) Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer 81:1274–1279Google Scholar